Pharmacological Analysis of the Anti-Epileptic Mechanisms of Fenfluramine in Scn1a Mutant Zebrafish

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2017.00191
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Drug Screening in Scn1a Zebrafish Mutant Identifies Clemizole as a Potential Dravet Syndrome Treatment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2013English

Early Infantile SCN1A Epileptic Encephalopathy: Expanding the Genotype-Phenotype Correlations

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2019English

Pharmacological Analysis of Ionotropic Glutamate Receptor Function in Neuronal Circuits of the Zebrafish Olfactory Bulb

PLoS ONE
Multidisciplinary
2008English

Pharmacological Modulation of Hemodynamics in Adult Zebrafish in Vivo

PLoS ONE
Multidisciplinary
2016English

Re-Annotation of 191 Developmental and Epileptic Encephalopathy-Associated Genes Unmasks De Novo Variants in SCN1A

npj Genomic Medicine
GeneticsMolecular Biology
2019English

Mechanisms of the Effects of Fenfluramine on Type II Diabetes Mellitus in Combination With Obesity

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1996English

Pharmacological Mechanisms, Clinical Effectiveness, and Side-Effects of Prostaglandin Analogues as Anti-Glaucoma Agents

Biomedical Reviews
BiochemistryMedicineGeneticsMolecular Biology
2002English

Cost Variation Analysis of Various Brands of Anti-Epileptic Drugs Currently Available in Indian Pharmaceutical Market

International Journal of Basic & Clinical Pharmacology
2017English

Analysis of SCN1A Mutation and Parental Origin in Patients With Dravet Syndrome

Journal of Human Genetics
Genetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy